Role of Interleukin- 34 together with Receptor Activator of Nuclear Factor kB ligand and Osteoprotegrin levels in Periodontal Disease

被引:0
|
作者
Ul Amin, Noor [1 ]
Qureshi, I. Saleem [2 ]
Naeem, Sana [3 ]
Jan, Syed Hassan [4 ]
Khan, Kamal [5 ]
Khan, Riaz [6 ]
Amin, Sadia [7 ]
Sahar, Tahira [8 ]
机构
[1] Frontier Med & Dent Coll Abbotabad, Periodont Dept, Abbotabad, Pakistan
[2] Frontier Med & Dent Coll, Dept Operat Dent, Abbottabad, Pakistan
[3] Frontier Med & Dent Coll, Oral Biol, Abbottabad, Pakistan
[4] Frontier Med & Dent Coll, Dept Oral Biol, Abbotabad, Pakistan
[5] Frontier Med & Dent Coll, Oral Pathol, Abbotabad, Pakistan
[6] Khyber Coll Dent, Oral & Maxillofacial Dept, Peshawar, Pakistan
[7] Govt Lady Reading Hosp, Oral & Maxillofacial Dept, Peshawar, Pakistan
[8] IOBM, MHM, Karachi, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 07期
关键词
Periodontitis; IL-34; osteoprotegrin; KAPPA-B LIGAND; EXPRESSION;
D O I
10.53350/pjmhs211571521
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To compare the levels and relative ratios of Interleukin-34, osteoprotegrin, and factor kB ligand in the crevicular fluid of individuals with periodontal disease. Study design & setting: Randomized Clinical Trial, Frontier Medical And Dental College, Abbotabad Methodology: We enrolled 15 healthy subjects (Group I), 15 patients with chronic periodontal disease (Group II) and 15 patients with aggressive periodontal disease (Group III). At baseline and six weeks after NSPT, crevicular fluid and clinical measures were made. The GCF IL-34, factor kB ligand, and osteoprotegrin levels were measured by using ELISA and their relative ratios were computed. Result: Group II and III had significantly higher crevicular fluid IL-34 and factor kB ligand levels than the Control group (I), although crevicular fluid with osteoprotegrin levels was significantly decreased (P<0.05). GCF, IL-34, and RANKL levels reduced in Groups II and III six weeks after NSPT, although OPG concentrations increased statistically (P<0.05). Significantly positive association was observed between IL-34 and factor kB ligand, clinical attachment level, and gingival index, but not with osteoprotegrin. Conclusion: Gingival crevicular fluid IL-34 levels were elevated in individuals with periodontal disease and lowered during non surgical intervention, and its levels correlated positively with the factor kB ligand and osteoprotegrin ratios, clinical attachment level, and gingival index.
引用
收藏
页码:1521 / 1522
页数:2
相关论文
共 34 条
  • [1] Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease
    Dogan, Seyma Bozkurt
    Dede, Figen Ongoz
    Balli, Umut
    Sertoglu, Erdim
    CYTOKINE, 2021, 144
  • [2] Serum levels of soluble receptor activator for nuclear factor kB ligand play a crucial role in the association of osteoprotegerin with coronary artery disease
    Zhou, Shaoqiong
    Wen, Hui
    Wang, Bin
    Guan, Siming
    Fang, Xin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 28 (02)
  • [3] Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
    Tabari, Zahra Alizadeh
    Azadmehr, Abbas
    Tabrizi, Mohammad Amir Alizadeh
    Hamissi, Jalaloddin
    Ghaedi, Fatemeh Baharak
    JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE, 2013, 43 (05) : 227 - 232
  • [4] Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing
    Colombini, Alessandra
    Lombardi, Giovanni
    Galliera, Emanuela
    Dogliotti, Giada
    Randelli, Pietro
    Meerssemann, Alexander
    Mineo, Giuseppe
    Cabitza, Paolo
    Corsi, Massimiliano Marco
    INTERNATIONAL ORTHOPAEDICS, 2011, 35 (05) : 777 - 782
  • [5] Gingival Crevicular Fluid, Serum Levels of Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Interleukin-17 in Patients With Rheumatoid Arthritis and Osteoporosis and With Periodontal Disease
    Gumus, Pinar
    Buduneli, Eralp
    Biyikoglu, Basak
    Aksu, Kenan
    Sarac, Fulden
    Nile, Christopher
    Lappin, David
    Buduneli, Nurcan
    JOURNAL OF PERIODONTOLOGY, 2013, 84 (11) : 1627 - 1637
  • [6] Serum Receptor Activator of Nuclear Factor-κ B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients
    Rashtchizadeh, Nadereh
    Ghorbanihaghjo, Amir
    Argani, Hassan
    Meimand, Saeed Mahmoudi
    Safa, Javid
    Vatankhahan, Hamidreza
    Shahidi, Maryam
    THERAPEUTIC APHERESIS AND DIALYSIS, 2012, 16 (06) : 600 - 604
  • [7] ROLE OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND (RANKL) AND OSTEOPROTEGERIN (OPG) IN PERIODONTAL BONE DESTRUCTION: A REVIEW
    Moon, Ninad
    Khan, Mohd. Inayatulla
    Moon, Archana
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (18): : 4781 - 4785
  • [8] Interleukin-12 Induces Receptor Activator of Nuclear Factor-Kappa B Ligand Expression by Human Periodontal Ligament Cells
    Ayuthaya, Benjar Issaranggun Na
    Everts, Vincent
    Pavasant, Prasit
    JOURNAL OF PERIODONTOLOGY, 2017, 88 (07) : E109 - E119
  • [9] Investigation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin levels in multiple sclerosis patients
    Kurban, Sevil
    Akpinar, Zehra
    Mehmetoglu, Idris
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2011, 36 (02): : 136 - 142
  • [10] Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis
    Gamal, Rania M.
    Gamal, Walid M.
    Ghandour, Abeer M.
    Abozaid, Hanan Sayed M.
    Mohamed, Mona Embarek
    Emad, Yasser
    Galeel, Ahmed Abdel
    IMMUNOLOGICAL INVESTIGATIONS, 2018, 47 (03) : 241 - 250